The invention relates to the use of Fc fragments of antibodies in the treatment of autoimmune and/or inflammatory diseases, said Fc fragments being isolated recombinant Fc fragments having a modified affinity for at least one of the Fc receptors (FcR), particularly an increased affinity to the FcRn.
申请公布号
WO2017006052(A2)
申请公布日期
2017.01.12
申请号
WO2016FR51708
申请日期
2016.07.06
申请人
LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES